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Abstract
Background: An improved prehospital diagnostic accuracy of cardiogenic pulmonary oedema could potentially
improve initial treatment, triage, and outcome. A pilot study was conducted to assess the feasibility, time-use, and
diagnostic accuracy of prehospital lung ultrasound (PLUS) for the diagnosis of cardiogenic pulmonary oedema.
Methods: A prospective observational study was conducted in a prehospital setting. Patients were included if the
physician based prehospital mobile emergency care unit was activated and one or more of the following two were
present: respiratory rate >30/min., oxygen saturation <90 %. Exclusion criteria were: age <18 years, permanent
mental disability or PLUS causing a delay in life-saving treatment or transportation. Following clinical assessment
PLUS was performed and presence or absence of interstitial syndrome was registered. Audit by three physicians
using predefined diagnostic criteria for cardiogenic pulmonary oedema was used as gold standard.
Results: A total of 40 patients were included in the study. Feasibility of PLUS was 100 % and median time used
was 3 min. The gold standard diagnosed 18 (45.0 %) patients with cardiogenic pulmonary oedema. The diagnostic
accuracy of PLUS for the diagnosis of cardiogenic pulmonary oedema was: sensitivity 94.4 % (95 % confidence
interval (CI) 72.7–99.9 %), specificity 77.3 % (95 % CI 54.6–92.2 %), positive predictive value 77.3 % (95 % CI 54.6–92.2 %),
negative predictive value 94.4 % (95 % CI 72.7–99.9 %).
Discussion: The sensitivity of PLUS is high, making it a potential tool for ruling-out cardiogenic pulmonary. The
observed specificity was lower than what has been described in previous studies.
Conclusions: Performed, as part of a physician based prehospital emergency service, PLUS seems fast and highly
feasible in patients with respiratory failure. Due to its diagnostic accuracy, PLUS may have potential as a prehospital
tool, especially to rule out cardiogenic pulmonary oedema.
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Background
Lung ultrasound (LUS) has over the last 20 years under-
gone a rapid development. From the viewpoint that the
lung was an organ that ultrasound could not be used to
investigate, several studies have shown that LUS can be
used for a variety of the most common diagnosis seen in
emergency medicine and traumatology [1, 2]. The prehos-
pital physician faces the difficult task of differentiating
between pulmonary and cardiac causes of acute
respiratory failure using only history and physical examin-
ation [3]. One way to distinguish between cardiac and pul-
monary causes of dyspnoea is to diagnose the presence of
pulmonary oedema. Cardiogenic pulmonary oedema can
with LUS be visualized as a characteristic pattern, the
interstitial syndrome (IS) [1, 4, 5]. Other conditions such
as non-cardiogenic pulmonary oedema, interstitial lung
disease, acute respiratory distress syndrome, interstitial
pneumonia can however also present itself as IS [1]. In
emergency settings cardiogenic pulmonary oedema is
however the most common cause of non-traumatic re-
spiratory failure, the finding of IS has thus pragmatically
been interpreted as being consistent with cardiogenic
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pulmonary oedema [4, 6]. This pragmatic assumption
has been validated in an emergency department setting
[5, 7]. Using this assumption LUS has been shown to
have a high diagnostic accuracy for the diagnosis of car-
diogenic pulmonary oedema which surpasses history
taking, clinical examination, blood samples and chest x-
ray [5]. Prehospital LUS (PLUS) to diagnose and ex-
clude pulmonary oedema is partly described in a single
case report and partly in a single prospective observa-
tional study [8, 9]. Additionally PLUS has been assessed
as a possible monitoring tool for prehospital treatment
of cardiogenic pulmonary oedema [10]. The results sug-
gest that PLUS have a high diagnostic accuracy for the
diagnosis of cardiac pulmonary oedema. Based on the
above, some of the potential benefits of PLUS for asses-
sing patients with acute respiratory failure are an in-
creased prehospital diagnostic accuracy of cardiogenic
pulmonary oedema, improved prehospital treatment of
these patients, and earlier and more accurate notification
of the receiving facility. A prospective pilot study was
conducted with the primary aim to assess the feasibility of
prehospital LUS in patients with signs of respiratory fail-
ure. Secondary aims were to assess time-use, and diagnos-
tic accuracy for cardiogenic pulmonary oedema.
Methods
Setting and study population
The study was conducted as a prospective cross-sectional
study of patients with respiratory failure in which Mobile
Emergency Care Unit (MECU) in Odense, Denmark, was
activated. The MECU in Odense consists of a rapid-
response car operating all year round, 24/7. The car is
manned with a specially trained emergency medicine tech-
nician and a physician with specialist training in anaesthe-
siology. Twelve physicians are employed at the MECU.
The MECU operates as part of a two-tiered system, in
which it supplements ambulances manned with either two
emergency medicine technicians or an emergency medi-
cine technician and a paramedic. The MECU covers an
area of approximately 2500 square km and serves a popu-
lation of 250,000 to 490,000 depending on time of the day.
In average the MECU is dispatched to 4900 calls per
year, corresponding to 13.5 calls per day. Patients with
respiratory symptoms admitted to hospital by the
MECU are either transported to the department of gen-
eral emergency medicine or the department of cardiology,
both located at Odense University Hospital, Denmark.
Inclusion and exclusion criteria
Patients were included if they fulfilled one or more of the
following two signs of respiratory failure: (1) respiratory rate
>30 breaths per minute or (2) peripheral oxygen saturation
without supplementary oxygen treatment <90 %. Patients
were excluded if they were below 18 years of age, if the
treating physician deemed that PLUS would delay life-
saving treatment or transportation, or if informed consent
could not be obtained due to permanent mental disability.
Initial prehospital presumptive diagnosis and treatment
The result of the initial prehospital assessment including
presumptive diagnosis and treatment initiated were pre-
hospitally registered, encrypted and stored using an iPad.
The data from the iPad were continuously transferred to
a separate study database.
Prehospital lung ultrasound examination
PLUS was performed using a SonoSite Edge (Bothell,
Washington, USA) ultrasound machine, with a microcon-
vex transducer (C11X)(8-5 mHz). As soon as the patient
had been included in the project, PLUS was performed.
The prehospital physician was allowed to decide whether
PLUS was made on-scene or en-route to the hospital. The
PLUS examination was performed using a standardized
protocol. Several different LUS protocols involving a wide
range of scanning zones have been described [1]. In the
present study a protocol based on a mixture of a protocol
described by Volpicelli et al. for use in an emergency de-
partment setting and a protocol described by Lichtenstein
et al. for use in an intensive care unit setting were used
[6, 11]. The transducer was placed in two scanning
zones (anterior and lateral) on each side of the patient’s
chest. In each scanning zone it was then noted whether
three or more B-lines were present or not. Based on
the PLUS findings it was then determined whether the
patient was positive or negative of having interstitial
syndrome. IS was defined as the presence of three or
more B-lines in a longitudinal plane between two ribs
in two or more of scanning fields, bilaterally. This def-
inition was based on the international consensus defin-
ition of IS, with the modification that the total number
of scanning zones were limited to two per side, rather
than four [1]. It was chosen to reduce the number of
scanning zones in order to decrease time used for the
examination. The results of the PLUS examination,
time used, and whether the findings had altered treat-
ment or the presumptive diagnosis were prehospitally
registered using the same iPad and system as described
above. Time used for PLUS was defined from the phys-
ician beginning to use the ultrasound machine (incl.
preparing the machine for use) to the transducer leav-
ing the skin of the patient after completing the examin-
ation. The department receiving the patient was
informed that the patient had been included in the
study but the result of the PLUS examination was
blinded. Prior to the initiation of the project, a short
training of all the physicians working at the physician
based prehospital emergency service was performed.
The training consisted of a theoretical lecture (45 min)
Laursen et al. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine  (2016) 24:96 Page 2 of 8
as well as practical demonstration involving hands-on
training of each physician (45 min). The physicians
manning the MECU were all specialists in anaesthesi-
ology and thus had basic competencies in ultrasound
for invasive procedures such as nerve blocks and vascu-
lar access. A few of the physicians had competencies in
transthoracic and transeosophageal echocardiography.
Only one of the physicians were experienced in the use
of lung ultrasound prior to the study.
Echocardiography
All included patients were as a part of the study referred for
echocardiography performed by a cardiologist. This was
done in order to systematically identify the enrolled patients’
cardiac status and to be able to identify any patients with
heart failure who had not been diagnosed as IS positive.
Blinded audit
The presence or absence of cardiogenic pulmonary
oedema was established using blinded audit. Two physi-
cians (AH (cardiologist), SP (emergency medicine phys-
ician)) independently of each other audited the patient’s
hospital stay. The two auditors used the following prede-
fined criteria to determine whether cardiac pulmonary
oedema was present or absent upon patient admission to
the hospital. At least two of the following three criteria
had to be met: (1) clinical signs of pulmonary oedema (e.g.
increased ventilation rate, hypoxemia, bilateral crackles
identified by auscultation), (2) imaging study with signs of
pulmonary oedema (chest X-ray, computed tomography
of the chest, LUS performed in the hospital) or (3) the
patient was diagnosed with a diseases which can be com-
plicated by pulmonary oedema (systolic heart failure as
part of the acute coronary syndrome, systolic heart failure,
non-systolic heart failure, hypertensive crisis, arrhythmia,
heart valve disease). In case of disagreement on the pres-
ence/non-presence of cardiac pulmonary oedema between
the two initial auditors, an additional audit was performed
by a third auditor (LV (cardiologist)) thus making the final
decision. All auditors were blinded towards the results
of the PLUS examination. The predefined diagnostic
criteria and audit method were based on two previously
conducted studies of patients with respiratory symp-
toms admitted to an emergency department [7, 12].
Statistical analysis
Descriptive statistics of demographic characteristics, med-
ical history, and initial vital signs were performed using
numbers, percentages, median and interquartile-range
(IQR). Descriptive statistics of the PLUS examination and
its possible clinical impact were performed including site
at which PLUS was performed, time used for PLUS, pro-
portion of patients in which PLUS had altered treatment,
or the prehospital presumptive diagnosis. The PLUS
feasibility was calculated as the proportion of included pa-
tients in which PLUS could be performed according to the
predefined ultrasound protocol. Agreement between the
two initial auditors was calculated as a proportion and
using the Cohen k test. The diagnostic accuracy of the
initial prehospital presumptive diagnosis and PLUS for
Table 1 Base-Line Characteristics of the Patients
Characteristic (n = 40)
Age - years
- Median (IQRa) 74 (67–81)
- Range 56–95
Sex – no. (%)
- Male 14 (35.0)
Smoking status – no. (%)
- Never smoked 5 (12.5)
- Current smoker 9 (23.5)
- Previous smoker 22 (55.0)
- Unknown status 4 (10.0)
Medical history – no. (%)
- COPD 21 (52.5)
- Asthma 1 (2.5)
- Interstitial lung disease 3 (7.5)
- Coronary artery disease 13 (32.5)
- Heart failure 4 (10.0)
- Valvular heart disease 4 (10.0)
- Arterial hypertension 19 (47.5)
- Thromboembolic disease 4 (10.0)
- Diabetes mellitus 8 (20.0)
- Stroke 5 (12.5)
- Current or previous malignancy 10 (25.0)
Medication at admission – no. (%)
- Inhaled bronchodilators 20 (50.0)
- Inhaled corticosteroids 16 (40.0)
- Oral corticosteroids 7 (17.5)
- Aspirin 11 (27.5)
- Clopidogrel 3 (7.5)
- Persantin 3 (7.5)
- Anticoagulants 10 (25.0)
- Beta-blockers 8 (20.0)
- ACE inhibitorsb 12 (30.0)
- Calcium-channel blockers 12 (30.0)
- Diuretics 22 (55.0)
- Digoxin 5 (12.5)
- Amiodarone 2 (5.0)
aInterquartile range (IQR) expressed as the 25 and 75th
bACE inhibitors denotes angiotensin-converting-enzyme inhibitor and
angiotensin receptor blocker
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the diagnosis of cardiogenic pulmonary oedema were
calculated. These calculations were expressed as sensitiv-
ity, specificity, positive predictive value (PPV), negative
predictive value (NPV), positive likelihood ratio (PLR),
negative likelihood ratio (NLR), and their 95 % confidence
intervals (CI). Blinded audit diagnosis was used as refer-
ence test for all calculations. Data analysis was conducted
using Stata Release version 11.0 (StataCorp LP).
Results
Between September 2013 and October 2014 a total of 45
patients were included in the study. Five patients in-
cluded were excluded upon arrival at the ED were infor-
mation from previous admissions revealed a diagnosis
consistent with permanent mental disability. Forty pa-
tients remained for study analysis. Baseline characteris-
tics of the included patients are provided in Table 1.
Feasibility of PLUS was 100 % and median time used for
the examination was 3 min (IQR 2–4 min). In all but
one patient (97.5 %), the PLUS examination was per-
formed on-scene prior to transportation of the patient
[13]. The 40 PLUS examinations were performed by
seven different physicians manning the MECU. In
27.5 % (95 % CI 13.0–42.0 %) of the patients PLUS find-
ings led to a change in the prehospital presumptive diag-
nosis and in 22.5 % (95 % CI 9.0–36.0 %) it also led to a
change in the initial prehospital treatment. Typical PLUS
findings are shown in Fig. 1. The median transport time
to the hospital was 10 min (IQR 5–15 min, range 4–20
min). Twenty-six (65.0 %) of the patients were admitted
to the department of general emergency medicine, 13
(32.5 %) to the department of cardiology, and one
(2.5 %) patient to the department of oncology. During
the hospital stay, six (15.0 %) patients received non-
invasive ventilation at the department of respiratory
medicine and 3 (7.5 %) patients were transferred to the
intensive care unit. The inhospital and 30-day mortality
was 7.5 % (95 % CI 0–16.0 %) and 15 % (95 % CI
3.4–26.6 %) respectively. The most common abnormal
echocardiography findings were: 14 (35 %) patients with
systolic heart failure, eight (20 %) patients with mitral
valve insufficiency and seven (17.5 %) patients with aortic
valve stenosis. Other findings were a dilated right ventricle
in five (12.5 %) patients and non-systolic heart failure in
two (5 %) patients. The blinded audit diagnosed 18
(45.0 %) patients with cardiogenic pulmonary oedema.
The overall agreement between the two initial auditors
for the diagnosis of cardiogenic pulmonary oedema was
87.5 % (k 0.746). When stratified according to a audit
diagnosis of presence or absence of cardiogenic pulmon-
ary oedema, significantly more patients received treatment
with nitroglycerin and diuretics in the cardiogenic pul-
monary oedema group, whereas significantly more pa-
tients received bronchodilators and systemic steroids in
the group in which cardiogenic pulmonary oedema was
absent (Table 2). The contingency tables and diagnostic
accuracy of the prehospital clinical assessment and
PLUS for the diagnosis of cardiogenic pulmonary
oedema are provided in Tables 3 and 4. No adverse
events related to the PLUS examination were observed.
Discussion
In a population of patients with respiratory failure, PLUS
was fast, highly feasible, and had an acceptable diagnos-
tic accuracy for the diagnosis of cardiogenic pulmonary
oedema. Especially the sensitivity of PLUS is high, mak-
ing it an excellent tool for ruling-out cardiogenic pul-
monary oedema, in the case of a PLUS examination with
no signs of IS. The specificity was however somewhat
lower and not better than the specificity of the clinical
assessment. A single prehospital study and several stud-
ies conducted in an in-hospital setting have found LUS
to have both a high sensitivity and specificity for the
diagnosis of cardiogenic pulmonary oedema [5, 8, 11].
One possible explanation for the lower specificity found
in this study might be the relatively high proportion of
patients with other conditions which may also cause IS,
as reflected by the proportion of patients in which the
Fig. 1 PLUS findings. a Image from a PLUS examination performed in a patient in which cardiogenic pulmonary oedema was absent. The pleuraline
(PL) appears as a hyperechoic (white), horizontal line. No B-lines are present. b Image from a PLUS examination performed in a patient with cardiogenic
pulmonary oedema. Multiple B-lines (arrows) are seen as hyperechoic (white), vertical, reverberation artefacts. The B-lines originate from the pleuraline
(PL) and extends to the bottom of the field of view without fading
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initial chest x-ray performed in the ED was described
with pulmonary fibrosis or possible interstitial lung
disease (Appendix, Table 6). Another possible reason for
the lower specificity might be the limited level of train-
ing in PLUS prior to the study. Studies assessing the
learning curve for focused LUS have however found
LUS to have a step learning curve for the diagnosis of IS
with a high diagnostic accuracy despite limited training
[14, 15]. A third possible explanation may be the gold
standard missing patients with cardiogenic pulmonary
oedema since chest x-ray often was the only imaging
modality used for pulmonary assessment in the patients.
Several studies have found focused LUS to have a higher
diagnostic accuracy than conventional chest x-ray for
the diagnosis of cardiogenic pulmonary oedema [1, 5].
Additionally, in the time gap between PLUS and initial
imaging at the hospital, the patient in most cases would
have received treatment and thereby reduce the severity
of the cardiogenic pulmonary oedema and thus the
changes which could be visualized by chest x-ray in the
ED. The transportation times were however relatively
short and the diagnostic criteria used for the gold stand-
ard did not solely rely on imaging findings. Based on the
k value, the agreement between the two auditors was
substantial according to Fleiss’ guidelines [16]. The PLUS
diagnostic criteria were based on the international defin-
ition of IS, using a definition in which multiple B-lines
had to be present in all four scanning zones or in both
of the two anterior zones might have improved the
PLUS specificity [1]. As indicated in other studies, such
a definition would however also have lead to a decreased
sensitivity and thereby also affect PLUS’ utility as an effi-
cient rule-out tool [17]. The PLUS protocol assessing
two zones on each hemithorax was chosen in order to
reduce the time used for the ultrasound examination.
The median time use of 3 min corresponds to what has
been reported using a three zone approach in an inten-
sive care setting and the eight zone approach in an ED
setting [6, 11]. The two zone approach did thus not
seem to reduce ultrasound examination time when
compared to a three or eight zone approach. This may
Table 2 Initial prehospital vital signs and treatment stratified
according to the presence or absence of cardiogenic pulmonary
oedema




Respiratory rate - breaths per minute
- Median (IQRc) 36 (32–42) 32 (30–36)
- Range 24–50 28–42
Saturation prior to oxygen treatment - %
- Median (IQRc) 80 (71–91) 85 (64–91)
- Range 54–98 50–98
Systolic blood pressure - mmHg
- Median (IQRc) 161 (130–210) 155 (120–177)
- Range 84–230 80–208
Diastolic blood pressure - mmHg
- Median (IQRc) 110 (80–121) 80 (66–100)
- Range 63–130 48–124
Heart rate – beats per minute
- Median (IQRc) 120 (112–150) 115 (91–134)
- Range 83–180 28–143
Glasgow Coma Score
- Median (IQRc) 15 (15–15) 15 (15–15)
- Range 15 13–15
Prehospital treatment administered – no. (%) (95 % CI)
Nitroglycerin 15 (83.3 %) 3 (13.6 %)
(64.3–100 %) (0–29.2 %)
Diuretic 16 (88.9 %) 7 (31.8 %)
(72.8–100) (10.7–53.0 %)
Opioid 5 (27.8 %) 3 (13.6 %)
(4.9–50.7 %) (0–29.2 %)
Amiodarone 2 (11.1 %) 0 (0 %)
(0–27.2 %) (0–13.6 %)
Acetylsalicylic acid 4 (22.2 %) 0 (0 %)
(0.9–43.5 %) (0–13.6 %)
Low molecular weight heparin 1 (5.6 %) 0 (0 %)
(0–17.3 %) (0–13.6 %)
Bronchodilator 3 (16.7 %) 17 (77.3 %)
(0–35.7 %) (58.3–96.2 %)
Systemic steroid 2 (11.1 %) 14 (63.4 %)
(0–27.2 %) (41.8–85.5 %)
Fluid resuscitation 1 (5.6 %) 2 (9.1 %)
(0–17.3 %) (0–22.1 %)
aResult of audit was presence of cardiogenic pulmonary oedema
bResult of audit was absence of cardiogenic pulmonary oedema
cInterquartile range (IQR) expressed as the 25 and 75th
Table 3 Contingency tables
Audit
CPOa Present CPOa absent Total
A
Clinical CPOa present 14 4 18
Assessment CPOa absent 4 18 22
Total 18 22 40
B
PLUS IS present 17 5 22
IS absent 1 17 18
Total 18 22 40
aCPO cardiogenic pulmonary oedema
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however be due to fact that relatively experienced or
specially trained physicians performed the LUS examina-
tions in the other studies [6, 11]. A direct comparison of
the time used for the different approaches performed by
the same physicians is thus needed to assess whether
there is a clinical significant time difference or not.
When compared to the diagnostic accuracy of the pre-
hospital clinical assessment, the clinical impact of using
PLUS as a standard diagnostic test in patients with re-
spiratory failure would be a fast and efficient means of
ruling-out cardiogenic pulmonary oedema. This would
have clinical important applications regarding several as-
pects. The use of inhaled bronchodilators in patients
with cardiogenic pulmonary oedema is associated with a
worse outcome [18]. In areas with long transportation
times to the nearest hospital, PLUS could potentially be
used to monitor treatment response during the transpor-
tation [10]. Prehospital ultrasound of trauma patient
seems to have a potential effect on prehospital triage
and selection of receiving facility [19]. PLUS could pos-
sible in the same manner be used to guide whether the
patient should be transferred to a cardiology department
or a general emergency department. PLUS may thus po-
tentially improve be prehospital treatment, monitoring
and transportation in patients with acute respiratory fail-
ure. Depending on how the prehospital and in-hospital
systems are organised, PLUS can be used to guide which
patients who do not have cardiogenic pulmonary
oedema and can thus safely be transported to a general
emergency department and to identify patients with a
high risk of cardiogenic pulmonary oedema needing ini-
tial assessment by a cardiologist.
Limitations
Being a single-MECU study, the results cannot necessar-
ily be applied to other MECUs or other prehospital set-
tings. Being a pilot study with a relatively small sample
size, the results has to be interpreted with caution, as
also reflected by the relatively wide 95 % CI’s of the re-
sults. The study results are however still useful for gen-
erating hypotheses for future studies. The physicians
performing the examinations only had limited PLUS
training, this would however reflect a “real-life-setting”
in which the MECU physician does not necessarily have
extensive skills and experience in focused ultrasound. In
some of the few published LUS learning studies, using
LUS to assess whether interstitial syndrome is present or
absent, a high diagnostic accuracy could be achieved even
after short training as used in the present study [14, 15,
20]. Even though patients were included prospectively, the
study results may have been affected by selection bias. No
registration was performed of the patients not included in
the study; hence no data are available for the screening
process for patient participation in the study. Since pa-
tients had to be able to give informed consent in order to
participate in the study, patients with very severe respira-
tory failure who could not give consent was not included.
Seen from a study design perspective, ideally all patients
with signs of respiratory failure should have been included
no matter whether consent could be given or not. Such a
design was however not possible in order to obtain ap-
proval from the Committee on Biomedical Research Eth-
ics. To what extent patients were not included due to
inclusion criteria not being met, due to the treating phys-
ician deemed that PLUS would delay life-saving treatment
or transportation, or due to patient not being able to give
informed consent is not known. Even though all the physi-
cians received the same training prior to the study, differ-
ences in ultrasound competencies prior to the study
might also have introduced selection bias if more experi-
enced sonographers were more likely to include patients.
Based on the average number of MECU activations per
year and the relatively common occurrence of patients
with respiratory failure one would expect that inclusion of
40 patients to the study could have been completed faster
than it did. There is thus a high risk of selection bias
being introduced in the patient recruitment process. To
what extent this has affected study results are unknown
due to the lack of available data.
Conclusion
Performed as a part of a physician based MECU, PLUS
seems fast and highly feasible in patients with respiratory
failure. Due to its diagnostic accuracy, PLUS may have
potential as a prehospital tool, especially to rule out car-
diogenic pulmonary oedema. Due to the relatively small
sample size, the results has to be interpreted with cau-
tion, the results are however still useful for generating
hypotheses for future studies.
Table 4 Diagnostic accuracy for the diagnosis of cardiogenic pulmonary oedema
Sensitivity (95 % CI) Specificity (95 % CI) PPVa (95 % CI) NPVb (95 % CI) PLRc (95 % CI) NLRd (95 % CI)
Clinical assessment 77.8 % (52.4–93.6 %) 81.8 % (59.7–94.8 %) 77.8 % (52.4–93.6 %) 81.8 % (59.7–94.8 %) 4.28 (1.7–10.7) 0.272 (0.112–0.659)
PLUS 94.4 % (72.7–99.9 %) 77.3 % (54.6–92.2 %) 77.3 % (54.6–92.2 %) 94.4 % (72.7–99.9 %) 4.16 (1.91–9.05) 0.072 (0.011–0.49)
aPPV positive predictive value
bNPV negative predictive value
cPLR positive likelihood ratio
dNLR negative likelihood ratio
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Appendix
Table 5 STARD checklist for reporting of studies of diagnostic
accuracy (version January 2003)
Section and Topic Item # On page #
TITLE/ABSTRACT/
KEYWORDS
1 Identify the article as a study of diagnostic accuracy (recommend MeSH heading ‘sensitivity
and specificity’).
p. 4
INTRODUCTION 2 State the research questions or study aims, such as estimating diagnostic accuracy or
comparing accuracy between tests or across participant groups.
p. 6
METHODS
Participants 3 The study population: The inclusion and exclusion criteria, setting and locations where data
were collected.
p. 6–7
4 Participant recruitment: Was recruitment based on presenting symptoms, results from previous
tests, or the fact that the participants had received the index tests or the reference standard?
p. 6
5 Participant sampling: Was the study population a consecutive series of participants defined by
the selection criteria in item 3 and 4? If not, specify how participants were further selected.
p. 6–7
6 Data collection: Was data collection planned before the index test and reference standard were
performed (prospective study) or after (retrospective study)?
p. 6
Test methods 7 The reference standard and its rationale. p. 9
8 Technical specifications of material and methods involved including how and when measurements
were taken, and/or cite references for index tests and reference standard.
p. 7–9
9 Definition of and rationale for the units, cut-offs and/or categories of the results of the index tests
and the reference standard.
p. 7–9
10 The number, training and expertise of the persons executing and reading the index tests and the
reference standard.
p. 7–9
11 Whether or not the readers of the index tests and reference standard were blind (masked) to the
results of the other test and describe any other clinical information available to the readers.
p. 7–9
Statistical methods 12 Methods for calculating or comparing measures of diagnostic accuracy, and the statistical methods
used to quantify uncertainty (e.g. 95 % confidence intervals).
p. 9–10
13 Methods for calculating test reproducibility, if done. %
RESULTS
Participants 14 When study was performed, including beginning and end dates of recruitment. p. 10
15 Clinical and demographic characteristics of the study population (at least information on age, gender,
spectrum of presenting symptoms).
Table 1
16 The number of participants satisfying the criteria for inclusion who did or did not undergo the index
tests and/or the reference standard; describe why participants failed to undergo either test
(a flow diagram is strongly recommended).
p. 10
Test results 17 Time-interval between the index tests and the reference standard, and any treatment administered
in between.
p. 9 + Table 2
18 Distribution of severity of disease (define criteria) in those with the target condition; other diagnoses
in participants without the target condition.
Table 2
19 A cross tabulation of the results of the index tests (including indeterminate and missing results) by
the results of the reference standard; for continuous results, the distribution of the test results by the
results of the reference standard.
Table 3
20 Any adverse events from performing the index tests or the reference standard. p. 11
Estimates 21 Estimates of diagnostic accuracy and measures of statistical uncertainty
(e.g. 95 % confidence intervals).
p. 10–11
Tables 2 + 4,
22 How indeterminate results, missing data and outliers of the index tests were handled. No missing
data
23 Estimates of variability of diagnostic accuracy between subgroups of participants, readers or centers,
if done.
Not done
24 Estimates of test reproducibility, if done. Not done
DISCUSSION 25 Discuss the clinical applicability of the study findings. p. 12–14
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